Skip to main content

AptarGroup, Inc. (ATR) Stock Analysis

Falling Knife setup

SellModerate Confidence

Healthcare · Medical Instruments & Supplies

Sell if holding. Momentum 1.4/10 is below the 5.0 floor at $115.81 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: V7 low-quality RISK_OFF penalty: -0.5 (Q=5.4); Weak growth.

AptarGroup designs and manufactures dosing, dispensing and protection technologies (pumps, aerosol valves, elastomeric pharma packaging, active material science) for pharma, beauty, food/beverage, and personal care markets across ~20 countries. The Pharma segment generates ~46%... Read more

$115.81+22.7% A.UpsideScore 5.3/10#17 of 25 Medical Instruments & Supplies
QualityF-score8 / 9FCF yield3.42%
IncomeYield1.63%(5y avg 1.26%)Payout31.85%sustainable
Stop $111.04Target $142.06(analyst − 13%)A.R:R 3.3:1
Analyst target$163.29+41.0%7 analysts
$142.06our TP
$115.81price
$163.29mean
$220

Sell if holding. Momentum 1.4/10 is below the 5.0 floor at $115.81 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: V7 low-quality RISK_OFF penalty: -0.5 (Q=5.4); Weak growth. Chart setup: Death cross, below all MAs, RSI 32, MACD bearish. Score 5.3/10, moderate confidence.

Passes 7/9 gates (favorable risk/reward ratio, clean insider activity, no SEC red flags, news events none recent, earnings proximity 72d clear, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum and death cross (50MA < 200MA). Suitability: moderate.

Recent Developments — AptarGroup, Inc.

Generated 2026-05-20T20:21:21Z.

Thesis

Rewards
Sector modifier (Healthcare): +0.5
Strong earnings beat streak (4/4)
Analyst upside: 23%
Risks
V7 low-quality RISK_OFF penalty: -0.5 (Q=5.4)
Weak growth
Negative momentum

Key Metrics

P/E (TTM)19.8
P/E (Fwd)18.5
Mkt Cap$7.4B
EV/EBITDA10.7
Profit Mgn10.0%
ROE14.8%
Rev Growth10.8%
Beta0.42
Dividend1.63%
Rating analysts12

Quality Signals

Piotroski F8/9MoatNarrow

Options Flow

P/C1.33bearish
IV38%normal
Max Pain$110-5.0% vs spot

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer

Rating Breakdown

2 floor-breakers

Price action weak — below key moving averages, no momentum carry. Needs a base before trend-continuation setups apply.static

Macd
0.0
Obv
1.0
Ma Position
1.0
Volume
1.5
Rsi
3.5
Volume distribution (falling OBV)Below 200-MA, MA slope -3.5%/30d — confirmed downtrend

Growth below the gate floor. Component breakdown shows what dragged the score down.static

Earnings Growth
1.1
Revenue Growth
5.2
GatesMomentum 1.4<4.5Death cross (50MA < 200MA)A.R:R 3.3 ≥ 1.5Insider activity: OKNo SEC red flagsNEWS EVENTS NONE RECENTEARNINGS PROXIMITY 72d clearSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARFalling KnifeSuitability: Moderate
RSI
32 · Neutral
20D MA 50D MA 200D MADEATH CROSSSupport $114.47Resistance $131.73

Price Targets

$111
$142
A.Upside+22.7%
A.R:R3.3:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeRisk-Off

Risk Alerts

! Momentum score 1.4/10 — below 4.5 minimum
! Death cross — 50-day MA below 200-day MA

Earnings

B
B
B
B
4/4 beats
Next Earnings2026-07-30 (72d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is ATR stock a buy right now?

Sell if holding. Momentum 1.4/10 is below the 5.0 floor at $115.81 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: V7 low-quality RISK_OFF penalty: -0.5 (Q=5.4); Weak growth. Chart setup: Death cross, below all MAs, RSI 32, MACD bearish. Prior stop was $111.04. Score 5.3/10, moderate confidence.

What is the ATR stock price target?

Take-profit target: $142.06 (+22.7% upside). Prior stop was $111.04. Stop-loss: $111.04.

What are the risks of investing in ATR?

V7 low-quality RISK_OFF penalty: -0.5 (Q=5.4); Weak growth; Negative momentum.

Is ATR overvalued or undervalued?

AptarGroup, Inc. trades at a P/E of 19.8 (forward 18.5). TrendMatrix value score: 6.6/10. Verdict: Sell.

What do analysts say about ATR?

12 analysts cover ATR with a consensus score of 4.1/5. Average price target: $163.

What does AptarGroup, Inc. do?AptarGroup designs and manufactures dosing, dispensing and protection technologies (pumps, aerosol valves, elastomeric...

AptarGroup designs and manufactures dosing, dispensing and protection technologies (pumps, aerosol valves, elastomeric pharma packaging, active material science) for pharma, beauty, food/beverage, and personal care markets across ~20 countries. The Pharma segment generates ~46% of 2025 net sales; Europe accounts for ~49% of consolidated sales. ~5,000 customers with no single customer exceeding 4% of net sales.

Related stocks: NVST (Envista Holdings Corporation) · MMSI (Merit Medical Systems, Inc.) · TFX (Teleflex Incorporated) · RMD (ResMed Inc.) · LMAT (LeMaitre Vascular, Inc.)